series-a
Stage
1
Investors
About
Targovax AS develops immuno-oncology therapies based on targeted cancer vaccines designed to activate the patient's immune system to attack tumors.
Explore Targovax AS's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.